Nasal Malignancy
This guideline applies to adults aged 18 years and over.
Introduction
Sinonasal malignancy is cancer affecting the nasal cavity and sinuses. It is rare in the UK with around 460 cases diagnosed each year1 and an incidence of 1:100,000.
Presentation is usually non-specific, often with unilateral symptoms that can mimic benign disease. The majority of nasal symptoms seen in primary care are attributable to common conditions such as rhinosinusitis, allergic rhinitis, and nasal polyposis.
Red flag features
Nasal cancer should be excluded in the context of new onset, persistent and/or rapidly progressive symptoms that can include
-
Nasal/ sinus
-
Unilateral facial pain and/or swelling
-
Unilateral bloody mucopurulent discharge/ unexplained epistaxis (simple epistaxis is also typically unilateral at presentation)
-
Unilateral facial pain and/or swelling
-
Orbital
-
Unilateral bulging eye, visual disturbance, painful eye movements and/or double vision
-
Unilateral bulging eye, visual disturbance, painful eye movements and/or double vision
-
Dental
- e.g. loosening of upper teeth
Please exclude other causes of simple epistaxis e.g. hypertension, trauma to anterior septum, nasal sprays
Risk factors for sinonasal malignancy
- Male
- Smoker
- Viruses: Human Papilloma Virus (HPV), Epstein-Barr Virus (EBV)
- Non-Hodkins Lymphoma
- Southeast Asian or North African descent
- First degree relative with sinonasal malignancy
- Recurrent exposure to: wood dust, leather dust, nickel, formaldehyde, cloth fibres
- Diet high in salt cured meats or fish
Investigations
No investigations are required or recommended prior to referral.
Referral Instructions
Refer any suspected nasal malignancy via E-RS on an URGENT basis clearly outlining the red flag symptoms. Referrals that do not clearly outline red flag symptoms will be downgraded to routine.
Do not send via Fast Track ENT Suspected Cancer.
References
- UCL NHS Foundation Trust – Nasal (nose) and sinus cancer
- UCL NHS Foundation Trust – Nasopharyngeal cancer
Page Review Information
|
Review date |
06 February 2026 |
|
Next review date |
06 February 2027 |
|
GP speciality lead |
Dr Jack Munro Berry |
|
Contributors |
Ms Aileen Lambert, Consultant ENT Surgeon Mr Neil Tan, Consultant ENT Surgeon |